Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Seth J. Welsh"'
Autor:
Erin Meermeier, Caleb K Stein, Meaghen E Sharik, Yuan Xiao Zhu, Megan T Du, Seth J Welsh, Chang-Xin Shi, Matthew L Wheeler, P. Leif Bergsagel, Marta Chesi
Publikováno v:
Blood. 140:7056-7057
Publikováno v:
Blood. 140:7082-7083
Autor:
Marta Chesi, Caleb K. Stein, Shaji Kumar, Seth J. Welsh, Yan W. Asmann, P. Leif Bergsagel, Daniel L. Riggs, Erin W. Meermeier, Esteban Braggio, Meaghen E. Sharik, Victoria M. Garbitt, Matteo Bergsagel
Publikováno v:
Blood Cancer Discov
The most common genetic abnormality in multiple myeloma is the deletion of chromosome 13, seen in almost half of newly diagnosed patients. Unlike chronic lymphocytic leukemia, where a recurrent minimally deleted region including MIR15A/MIR16-1 has be
Publikováno v:
Frontiers in Aging Neuroscience, Vol 7 (2015)
We examined aging-related differences in the contribution of visuomotor correction to force fluctuations during index finger abduction via the analysis of two datasets from similar subjects. Study 1) Young (N= 27, 23+/-8 yrs) and older adults (N=14,
Externí odkaz:
https://doaj.org/article/1129114fe04d4c77b785d03883aad22c
Autor:
Seth J Welsh, Benjamin G Barwick, Erin Meermeier, Daniel Riggs, Chang-Xin Shi, Yuan Xiao Zhu, Meaghen E Sharik, Megan T Du, Victoria Marie Garbitt, Caleb K Stein, Joachim L Petit, Nathalie Meurice, Rodrigo Fonseca, Kennedi Todd, Sochilt Brown, Yuliza Tafoya Alvarado, Zachary Hammond, Nicklus Cuc, Courtney Wittenberg, Camille Herzog, Lawrence H. Boise, Nizar J. Bahlis, Paola Neri, W. Michael Kuehl, Marta Chesi, P. Leif Bergsagel
Publikováno v:
Blood. 140:12997-12997
Autor:
Pavel Strop, P. Leif Bergsagel, Marta Chesi, Megan T. Du, Matthew L. Wheeler, Bryant Chau, Victoria M. Garbitt, Marco Bergsagel, Natalie Bezman, Caleb K. Stein, Chang-Xin Shi, Meaghen E. Sharik, Feng Wang, Daniel L. Riggs, Erin W. Meermeier, Seth J. Welsh
Publikováno v:
Blood Cancer Discov
BCMA/CD3-targeting bispecific antibodies (BsAb) are a recently developed immunotherapy class that shows potent tumor killing activity in multiple myeloma. Here, we investigated a murine BCMA/CD3-targeting BsAb in the immunocompetent Vk*MYC model and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fb9f36adc448e13bc6a0a5e8f268bc3
https://europepmc.org/articles/PMC8266040/
https://europepmc.org/articles/PMC8266040/
Autor:
Erin W. Meermeier, Seth J. Welsh, Meaghen Sharik, Megan T. Du, Chang-Xin Shi, Bryant Chau, Feng Wang, Matthew Wheeler, Natalie Bezman, Pavel Strop, P. Leif Bergsagel, Marta Chesi
Publikováno v:
Cancer Research. 82:5588-5588
Bispecific T cell engagers (TCE) are novel immunotherapies for cancer that redirect a synthetic immune response against tumors. Early clinical trial data show that BCMA-targeting TCEs are highly effective immunotherapies for treating relapsed and ref
Autor:
Megan Du, Lawrence H. Boise, P. Leif Bergsagel, Sochilt Brown, Chang-Xin Shi, Meaghen E. Sharik, Marta Chesi, Kennedi T. Todd, Victoria M. Garbitt, Benjamin G. Barwick, Zachary J. Hammond, Caleb K. Stein, Paola Neri, Nizar J. Bahlis, Daniel L. Riggs, Erin W. Meermeier, Seth J. Welsh, W. Michael Kuehl
Publikováno v:
Blood. 138:1593-1593
Multiple myeloma (MM) is an incurable form of plasma cell cancer in which primary and secondary chromosomal translocations routinely juxtapose oncogenes to plasma cell-specific super-enhancers. Coincidentally, drugs which target super-enhancers have
Autor:
Daniel L. Riggs, Caleb K. Stein, A. Keith Stewart, K. Martin Kortüm, Shaji Kumar, Yan W. Asmann, Robert A. Kyle, P. Leif Bergsagel, Grady Day, Jonathan J Keats, Greg J. Ahmann, Niamh Keane, S. Vincent Rajkumar, David S. Viswanatha, Marta Chesi, Scott Van Wier, Kristine Misund, Angela Dispenzieri, Verónica González-Calle, Esteban Braggio, Michael O'Dwyer, Seth J. Welsh, Rafael Fonseca, W. Michael Kuehl
Publikováno v:
Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36b4258c806d6f2400ce1ac6bd447ede
http://hdl.handle.net/11250/2641175
http://hdl.handle.net/11250/2641175
Autor:
Sochilt Brown, Marco Bergsagel, Marta Chesi, P. Leif Bergsagel, Victoria M. Garbitt, Erin W. Meermeier, Kennedi T. Todd, Caleb K. Stein, Meaghen E. Sharik, Seth J. Welsh
Publikováno v:
Cancer Research. 80:5630-5630
BCMA is an ideal target antigen for myeloma immunotherapy as it is specifically expressed by plasma cells and T cell-engaging, BCMA-bispecific antibodies show potent tumor killing activity in human multiple myeloma (MM). However, a lack of longevity,